Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 3/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053182 | 0.91 | CA1 (0.61) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500198 | 0.90 | CA1 (0.59) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500789 | 0.89 | CA1 (0.54) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500871 | 0.84 | CA1 (0.53) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500365 | 0.84 | CA1 (0.45) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500064 | 0.83 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500011 | 0.83 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL500067 | 0.83 | CA1 (0.49) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL10053145 | 0.82 | CA1 (0.48) | CA1CA2PDE3APDE4APDE4B | |
| SCHEMBL596933 | 0.81 | PDE3A (0.50) | CA1CA2PDE3APDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240206470-A1 | VOLATILE APPLICATIONS AGAINST PATHOGENS | AGROFRESH INC (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240206470-A1 | VOLATILE APPLICATIONS AGAINST PATHOGENS | AGROFRESH INC (US) | 2024-06-27 | — | — | US | disclosed |
| US-11771089-B2 | Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | AGROFRESH INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771089-B2 | Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | AGROFRESH INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20220361503-A1 | LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS | ALTER DOMUS US LLC | 2022-11-17 | — | — | US | disclosed |
| US-11202448-B2 | Volatile applications against pathogens | AGROFRESH INC. (US) | 2021-12-21 | — | — | US | disclosed |
| EP-3148551-B1 | VOLATILE APPLICATIONS AGAINST PATHOGENS | AGROFRESH INC (US) | 2021-09-29 | — | — | EP | disclosed |
| US-11039617-B2 | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | AGROFRESH INC. (US) | 2021-06-22 | — | — | US | disclosed |
| EP-3424932-B1 | BORONOPHTHALIDES FOR THERAPEUTIC USE | ANACOR PHARMACEUTICALS INC (US) | 2021-04-07 | — | — | EP | disclosed |
| US-20210070780-A1 | Boron-Containing Small Molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2021-03-11 | — | — | US | disclosed |
| WO-2007131072-A2 | HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007131072-A2 | HYDROLYTICALLY-RESISTANT BORON-CONTAINING THERAPEUTICS AND METHODS OF USE | ANACOR PHARMACEUTICALS, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| US-20070265226-A1 | Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use | ANACOR PHARMACEUTICALS (US) | 2007-11-15 | — | — | US | disclosed |
| US-20070265226-A1 | Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use | ANACOR PHARMACEUTICALS (US) | 2007-11-15 | — | — | US | disclosed |
| WO-2007078340-A2 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007078340-A2 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070155699-A1 | Boron-containing small molecules | ANACOR PHARMACEUTICALS (US) | 2007-07-05 | — | — | US | disclosed |
| WO-2006089067-A2 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11202448-B2 | Volatile applications against pathogens | OXA1L, VAPB, TIAL1 | CA1 3741/4885CA2 3017/4885PDE3A 3288/4885 |
| US-20240206470-A1 | VOLATILE APPLICATIONS AGAINST PATHOGENS | OXA1L, VAPB, TIAL1 | CA1 3741/4885CA2 3017/4885PDE3A 3288/4885 |
| US-11039617-B2 | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | FOSB, TAS2R10, TMBIM6 | CA1 3842/4885CA2 3591/4885PDE3A 2017/4885 |
| US-20070155699-A1 | Boron-containing small molecules | ETF1, POLR1C, DPM1 | CA1 4091/4885CA2 1368/4885PDE3A 4505/4885 |
| US-20210070780-A1 | Boron-Containing Small Molecules | ETF1, POLR1C, DPM1 | CA1 4091/4885CA2 1368/4885PDE3A 4505/4885 |
| US-11771089-B2 | Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | TAS2R10, FOSB, TMBIM6 | CA1 3929/4885CA2 3745/4885PDE3A 2224/4885 |
| US-20070265226-A1 | Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use | GAA, BTD, MANBA | CA1 838/4885CA2 535/4885PDE3A 3530/4885 |
| US-20220361503-A1 | LARGE-SCALE METHODS OF UNIFORMLY COATING PACKAGING SURFACES WITH A VOLATILE ANTIMICROBIAL TO PRESERVE FOOD FRESHNESS | TAS2R10, FOSB, TMBIM6 | CA1 3929/4885CA2 3745/4885PDE3A 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.